Back
Alnylam Pharmaceuticals Stock Predictions
20 Most Hated Stocks on Wall Street
Click here to see the full list and protect yourself before it's too late.
Sell
33
ALNY
Alnylam Pharmaceuticals
Last Price:
149.97
Seasonality Move:
23.32%
7 Day Trial
ALL ACCESS PASS
$
7
My #1 Coin is...
All the details are on the next page.Alnylam Pharmaceuticals Stock Forecast
- Over the next 52 weeks, Alnylam Pharmaceuticals has on average historically risen by 29.9% based on the past 19 years of stock performance.
- Alnylam Pharmaceuticals has risen higher in 10 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 52.63%
-
Is Alnylam Pharmaceuticals Stock Undervalued?
The current Alnylam Pharmaceuticals [ALNY] share price is $150.47. The Score for ALNY is 33, which is 34% below its historic median score of 50, and infers higher risk than normal. - ALNY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Alnylam Pharmaceuticals Stock Go Up Next Year?
- Over the next 52 weeks, Alnylam Pharmaceuticals has on average historically risen by 29.9% based on the past 19 years of stock performance.
Alnylam Pharmaceuticals Stock Rating
Sell
33
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals overpriced?
- Alnylam Pharmaceuticals has risen higher in 10 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 52.63%
Alnylam Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
alnylam.com
52-Week Data
52-Week High:
218.88
52-Week Low:
141.98
Prediction Charts
Market Cap:
19.03B
Price in USD:
150.47
Volume:
322.71K
Beta:
1.16
Technical Analysis
SMA50:
149.38
SMA100:
163.56
SMA200:
170.28
52-Wk Change:
-28.68%
Stock Predictions
-
Is Alnylam Pharmaceuticals stock public?
Yes, Alnylam Pharmaceuticals is a publicly traded company. -
What is the Alnylam Pharmaceuticals stock quote today?
The Alnylam Pharmaceuticals stock price is 150.47 USD today. -
How to buy Alnylam Pharmaceuticals stock online?
You can buy Alnylam Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Apr-23 | 147.35 | 146.06 | 150.27 | 145.04 |
| Apr-24 | 146.60 | 143.80 | 147.49 | 143.52 |
| Apr-25 | 143.00 | 143.71 | 145.79 | 141.98 |
| Apr-26 | 144.08 | 143.31 | 146.07 | 143.00 |
| Apr-29 | 144.91 | 147.36 | 148.49 | 143.50 |
| Apr-30 | 146.07 | 143.83 | 148.05 | 143.81 |
| May-1 | 144.21 | 149.96 | 151.95 | 143.96 |
| May-2 | 150.80 | 150.31 | 153.85 | 147.29 |
| May-3 | 154.41 | 152.33 | 155.41 | 151.84 |
| May-6 | 152.82 | 151.24 | 152.82 | 149.52 |
| May-7 | 152.42 | 154.25 | 155.11 | 150.83 |
| May-8 | 154.08 | 152.29 | 155.49 | 152.19 |
| May-9 | 153.00 | 151.37 | 153.00 | 150.37 |
| May-10 | 151.81 | 150.47 | 151.81 | 148.75 |
Alnylam Pharmaceuticals Earnings
Alnylam Pharmaceuticals Earnings Report: Per Share Alnylam Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Alnylam Pharmaceuticals Forecast Revenue Growth
Alnylam Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Alnylam Pharmaceuticals and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.34 per share, a decrease next quarter of $0.14 per share, a decrease this year of $0.52 per share, and an increase next year of $1.84 per share.
* Alnylam Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.